The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2010Ghrelin - a Peripheral, Preclinical Biomarker for Parkinson's Disease
Promising Outcomes of Original Grant:
In our original grant we investigated serum concentrations of the hormone ghrelin in the fasting state and at different time points after a standardized test meal... -
Rapid Response Innovation Awards, 2010Dopamine D1-D3 Receptor Heteromer as a New Target for Parkinson's Disease
Objective/Rationale:
Receptor heteromers must be understood as dimeric or higher order molecular entities that are the result of combinatorial evolution and that are endowed with unique... -
Rapid Response Innovation Awards, 2010Screen for Novel Glucocerebrosidase-Interacting Parkinson's Genes
Objective/Rationale:
Our goal is to discover new genes that lead to Parkinson’s disease. Most of the known causes of Parkinson’s disease are rare and account for a minority of patients. However, it... -
Rapid Response Innovation Awards, 2010Nasal PD Treatment-Proof-of-Concept
Objective/Rationale:
- In animal models of PD, brain injections of certain neurotrophic factors prevent degeneration of midbrain dopaminergic neurons.
- Clinical testing of brain injected gene vectors...
-
Rapid Response Innovation Awards, 2010Functional Genomic Screening to Identify Novel Regulators of Parkin
Objective/Rationale:
In normal cells, Parkin protein senses damage of critical cellular organelles known as mitochondria and promotes recycling of their contents. Mitochondria are the energy... -
MJFF Research Grant, 2010Role of H1N1 Influenza Virus in the Etiology of Parkinson's Disease
Objective/Rationale:
Viruses (including influenza) have also been proposed to be an etiological agent for PD based on the appearance of otherwise non-explained clusters of parkinsonism. Recently...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.